[PHARMA] YoY TTM Result on 30-Sep-2005 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
22-Nov-2005
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2005
Quarter
30-Sep-2005 [#3]
Profit Trend
QoQ- -16.44%
YoY- -16.4%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Revenue 1,270,220 1,158,107 1,035,136 892,999 765,831 595,774 594,966 13.46%
PBT 89,675 53,669 28,509 63,679 78,178 59,464 64,797 5.55%
Tax -29,741 -21,710 -9,932 -23,646 -31,216 -21,424 -26,084 2.20%
NP 59,934 31,959 18,577 40,033 46,962 38,040 38,713 7.54%
-
NP to SH 58,311 30,331 17,173 39,258 46,962 38,040 38,713 7.05%
-
Tax Rate 33.17% 40.45% 34.84% 37.13% 39.93% 36.03% 40.25% -
Total Cost 1,210,286 1,126,148 1,016,559 852,966 718,869 557,734 556,253 13.81%
-
Net Worth 374,393 335,784 323,095 275,634 256,815 211,489 172,829 13.73%
Dividend
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Div 38,516 16,038 12,310 18,973 16,578 8,506 5,002 40.48%
Div Payout % 66.05% 52.88% 71.69% 48.33% 35.30% 22.36% 12.92% -
Equity
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Net Worth 374,393 335,784 323,095 275,634 256,815 211,489 172,829 13.73%
NOSH 106,969 106,937 106,985 104,012 101,508 100,232 50,095 13.46%
Ratio Analysis
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
NP Margin 4.72% 2.76% 1.79% 4.48% 6.13% 6.38% 6.51% -
ROE 15.57% 9.03% 5.32% 14.24% 18.29% 17.99% 22.40% -
Per Share
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
RPS 1,187.46 1,082.97 967.55 858.55 754.45 594.39 1,187.67 -0.00%
EPS 54.51 28.36 16.05 37.74 46.26 37.95 77.28 -5.64%
DPS 36.00 15.00 11.50 18.24 16.50 8.50 10.00 23.77%
NAPS 3.50 3.14 3.02 2.65 2.53 2.11 3.45 0.23%
Adjusted Per Share Value based on latest NOSH - 104,012
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
RPS 88.13 80.35 71.82 61.96 53.14 41.34 41.28 13.46%
EPS 4.05 2.10 1.19 2.72 3.26 2.64 2.69 7.05%
DPS 2.67 1.11 0.85 1.32 1.15 0.59 0.35 40.26%
NAPS 0.2598 0.233 0.2242 0.1912 0.1782 0.1467 0.1199 13.74%
Price Multiplier on Financial Quarter End Date
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Date 30/09/08 28/09/07 29/09/06 30/09/05 30/09/04 30/09/03 30/09/02 -
Price 3.24 3.27 3.98 4.95 4.77 4.55 7.68 -
P/RPS 0.27 0.30 0.41 0.58 0.63 0.77 0.65 -13.60%
P/EPS 5.94 11.53 24.79 13.11 10.31 11.99 9.94 -8.21%
EY 16.82 8.67 4.03 7.62 9.70 8.34 10.06 8.93%
DY 11.11 4.59 2.89 3.69 3.46 1.87 1.30 42.93%
P/NAPS 0.93 1.04 1.32 1.87 1.89 2.16 2.23 -13.55%
Price Multiplier on Announcement Date
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Date 24/11/08 22/11/07 13/11/06 22/11/05 26/11/04 14/11/03 22/11/02 -
Price 3.35 3.42 3.65 4.82 4.77 5.00 7.36 -
P/RPS 0.28 0.32 0.38 0.56 0.63 0.84 0.62 -12.39%
P/EPS 6.15 12.06 22.74 12.77 10.31 13.17 9.52 -7.01%
EY 16.27 8.29 4.40 7.83 9.70 7.59 10.50 7.56%
DY 10.75 4.39 3.15 3.78 3.46 1.70 1.36 41.09%
P/NAPS 0.96 1.09 1.21 1.82 1.89 2.37 2.13 -12.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment